Company attributes
Venture Capital Firm attributes
Other attributes
Synergy Partners International is a Menlo Park, California venture capital firm. Since 1996, Synergy has made equity investments in United States medical technology companies and medical device companies and leading medical technology companies. Their main focus are startup companies developing medical devices and diagnostic products.
Synergy Partners International develops corporate partnerships with Japanese companies, and these partnerships are offered to their portfolio companies. Synergy Partners International seeks seed and early stage setups where they offer $250,000 to $1 million as an initial investment.
Synergy Partners International has made investments in Aria, Arrinex, Autonomix, Breathe Technologies, Cagent Vascular, Marblehead Medical, NeoCis, Neptune Medical, NeuroSave, Palmera Medical, Paradromics, Pulson, ReLign Corporation, Respirix, RODO Medical, Sevident and ThrombX Medical.
They exited their investment in Breathe Technologies.
